Drug Development

Meiji Seika Pharma has entered into a strategic collaboration with MBC BioLabs to deepen its global drug discovery innovation partnership and strengthen external research...

Astellas Pharma has entered a strategic partnership with Autobahn Labs to accelerate the translation of academic research into novel drug discovery and development programs,...

Zealand Pharma, OTR Therapeutics sign collaboration through a strategic collaboration and license agreement to discover and develop new therapies for metabolic diseases. The deal...

The U.S. Food and Drug Administration (FDA) has approved inebilizumab-cdon (Uplizna; Amgen) for the treatment of adults with generalized myasthenia gravis who are anti-acetylcholine...

Pharmaceutical quality management is fundamentally transforming from reactive approaches detecting quality issues after production toward proactive systems predicting and preventing quality problems before they occur. This comprehensive article analyzes how risk modeling, predictive analytics, automated corrective action insights, and real-time quality dashboards shift quality assurance from retrospective testing to predictive control, enabling pharmaceutical manufacturers to improve product reliability while reducing quality costs and accelerating quality decision-making through digital intelligence systems.

Pharmaceutical manufacturing is undergoing fundamental paradigm shifts toward efficiency-driven models incorporating automation-assisted workflows, human-machine collaboration, flexible production lines, and continuous manufacturing approaches. This comprehensive analysis examines how manufacturers modernize facilities to reduce cycle times, minimize variability, and enhance operational robustness while maintaining absolute compliance with FDA and international regulatory requirements that define pharmaceutical production.

Innovations in pharmaceutical manufacturing equipment—including advanced mixing, filtration, separation, and material handling technologies—enable tighter process control and reduced variability across production runs. This comprehensive analysis examines how modern process equipment improves consistency through enhanced control, superior design, and integration with digital monitoring systems while enabling pharmaceutical manufacturers to achieve stringent quality requirements and process optimization objectives.